| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,354 |
1,265 |
$278K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
15,085 |
9,459 |
$221K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
17,076 |
10,795 |
$126K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
3,885 |
2,768 |
$121K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,541 |
1,413 |
$118K |
| 71046 |
Radiologic examination, chest; 2 views |
3,695 |
3,365 |
$54K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
10,820 |
3,092 |
$48K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
4,818 |
4,131 |
$37K |
| 80053 |
Comprehensive metabolic panel |
13,078 |
10,953 |
$25K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
183 |
175 |
$19K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
15,146 |
12,127 |
$18K |
| 71045 |
Radiologic examination, chest; single view |
1,525 |
1,360 |
$18K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
165 |
154 |
$17K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
5,330 |
4,104 |
$15K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
338 |
329 |
$10K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
3,739 |
3,002 |
$9K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,386 |
921 |
$8K |
| 71250 |
|
71 |
63 |
$8K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
970 |
521 |
$7K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,952 |
2,808 |
$7K |
| 84484 |
|
3,896 |
3,093 |
$6K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
256 |
234 |
$5K |
| 93307 |
|
32 |
31 |
$4K |
| 73030 |
|
180 |
161 |
$4K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
1,323 |
436 |
$4K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,097 |
2,020 |
$4K |
| 97162 |
|
532 |
497 |
$4K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
692 |
640 |
$4K |
| 36415 |
Collection of venous blood by venipuncture |
8,949 |
6,423 |
$4K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
290 |
236 |
$3K |
| 72100 |
|
110 |
99 |
$3K |
| 90832 |
Psychotherapy, 30 minutes with patient |
812 |
472 |
$3K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
926 |
694 |
$3K |
| 87631 |
|
1,746 |
1,632 |
$3K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,224 |
1,972 |
$3K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
1,111 |
826 |
$2K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
107 |
77 |
$2K |
| 83735 |
|
3,648 |
3,083 |
$2K |
| 85610 |
|
2,977 |
1,720 |
$2K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
118 |
60 |
$2K |
| 81001 |
|
3,478 |
3,063 |
$2K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
4,318 |
3,736 |
$2K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
13 |
12 |
$2K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
185 |
146 |
$2K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
555 |
484 |
$2K |
| 71271 |
|
26 |
24 |
$2K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
256 |
137 |
$2K |
| 83880 |
|
387 |
327 |
$2K |
| 83690 |
|
2,388 |
2,111 |
$1K |
| 73630 |
|
143 |
131 |
$1K |
| 73564 |
|
93 |
79 |
$1K |
| 83605 |
|
1,442 |
1,168 |
$1K |
| 85027 |
|
4,252 |
3,326 |
$1K |
| 80061 |
Lipid panel |
2,086 |
2,006 |
$1K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
508 |
234 |
$1K |
| J2704 |
Injection, propofol, 10 mg |
525 |
383 |
$1K |
| 81003 |
|
2,157 |
1,998 |
$964.41 |
| 82948 |
|
1,840 |
1,086 |
$961.23 |
| 86140 |
|
1,779 |
1,545 |
$865.06 |
| 97161 |
|
77 |
74 |
$845.34 |
| 87186 |
|
928 |
835 |
$831.74 |
| 82043 |
|
245 |
226 |
$797.13 |
| 73610 |
|
91 |
83 |
$722.31 |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
459 |
406 |
$701.76 |
| 84439 |
|
433 |
409 |
$695.73 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,995 |
1,856 |
$670.39 |
| 76830 |
Ultrasound, transvaginal |
29 |
29 |
$654.76 |
| 85379 |
|
582 |
546 |
$637.84 |
| 96361 |
Intravenous infusion, hydration; each additional hour |
49 |
37 |
$611.33 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
143 |
80 |
$563.86 |
| Q3014 |
Telehealth originating site facility fee |
497 |
278 |
$514.33 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
342 |
330 |
$500.14 |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
894 |
865 |
$469.48 |
| 85004 |
|
120 |
114 |
$465.89 |
| 87040 |
|
313 |
286 |
$451.89 |
| 82728 |
|
350 |
328 |
$449.92 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
734 |
706 |
$449.67 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,563 |
1,302 |
$419.55 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,287 |
1,137 |
$375.01 |
| 85730 |
|
201 |
176 |
$373.03 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
405 |
346 |
$361.87 |
| 90791 |
Psychiatric diagnostic evaluation |
99 |
96 |
$338.25 |
| 73502 |
|
16 |
13 |
$317.01 |
| 82607 |
|
118 |
108 |
$307.12 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
204 |
200 |
$300.05 |
| 84100 |
|
261 |
223 |
$238.39 |
| 83540 |
|
217 |
202 |
$222.12 |
| 83550 |
|
171 |
159 |
$206.07 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
244 |
196 |
$192.46 |
| 85651 |
|
212 |
187 |
$175.33 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
826 |
801 |
$164.37 |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
12 |
12 |
$135.55 |
| 99217 |
|
27 |
25 |
$119.40 |
| 90715 |
|
12 |
12 |
$119.38 |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
160 |
55 |
$116.02 |
| J2060 |
Injection, lorazepam, 2 mg |
84 |
68 |
$107.21 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
65 |
53 |
$106.74 |
| 73110 |
|
31 |
28 |
$92.65 |
| 87077 |
|
68 |
61 |
$63.33 |
| 80305 |
|
184 |
172 |
$61.42 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
27 |
27 |
$53.22 |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
43 |
39 |
$51.70 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
37 |
29 |
$41.10 |
| 87081 |
|
365 |
357 |
$33.51 |
| 87088 |
|
76 |
71 |
$31.83 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
17 |
14 |
$27.63 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
34 |
25 |
$27.59 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
14 |
14 |
$21.40 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
12 |
12 |
$18.72 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
18 |
14 |
$15.04 |
| 81025 |
|
302 |
289 |
$5.78 |
| 82570 |
|
31 |
29 |
$4.02 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
27 |
26 |
$2.01 |
| 85008 |
|
61 |
56 |
$1.71 |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
105 |
100 |
$0.31 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
46 |
42 |
$0.06 |
| 90837 |
Psychotherapy, 53 minutes with patient |
39 |
34 |
$0.00 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
13 |
13 |
$0.00 |